Phone app aims to ease the mental toll of leukemia treatment
NCT ID NCT06472128
Summary
This study is testing whether a smartphone app called DREAMLAND can help improve the quality of life and emotional well-being of adults with acute myeloid leukemia (AML) while they are in the hospital for intensive chemotherapy. The app provides coping skills, education, and psychological support. Researchers will compare the app's effects to a different health app in 200 participants to see if it better reduces anxiety, depression, and symptom burden.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Duke University
NOT_YET_RECRUITINGDurham, North Carolina, 27710, United States
Contact Email: •••••@•••••
-
Fred Hutchinson Cancer Research Center (FHCRC)
NOT_YET_RECRUITINGSeattle, Washington, 98109, United States
Contact Email: •••••@•••••
-
Massachusetts General Hospital (MGH)
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.